UNSPSC 51352202: Broparestrol

This classification denotes a therapeutic estrogen with the molecular formula C22H19Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7U06D381UQ, chemically known as 2-brom-1-(4-ethylphenyl)-1,2-diphenylethylen but generally known as broparestrol, which bears US NIH Compound Identifier 3032769. European Medicines Agency schedules Broparestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05926MIG. The term BROPARESTROL is an International Non-Proprietary Name.

UNSPSC 51352202 Broparestrol is a Commodity code covering a pharmaceutical active ingredient used in veterinary and animal health applications. State and local governments procure broparestrol primarily through public health departments, animal control agencies, and veterinary services divisions for livestock management, animal welfare programs, and disease prevention in managed animal populations. The code captures a narrow, specialized product category with limited direct procurement by most jurisdictions; demand concentrates among state departments of agriculture, state veterinary boards, and county animal services operations that manage breeding programs or treat animals in public custody.

The most-recent-state-local-contract-opportunities block provided no records for this code, indicating minimal or no recent solicitation activity at the state and local level. No representative opportunities, issuing bodies, geographic distribution, or response dates are available to characterize current market activity. Organizations evaluating pursuit under this code should verify whether state and local customers are sourcing broparestrol through cooperative purchasing agreements, standing contracts with animal health suppliers, or direct purchase from pharmaceutical vendors rather than through public procurement channels.